Katerina Bittenglova

Katerina Bittenglova

Auto-generated profile, based on publicly available information

Katerina Bittenglova

Institute for Clinical and Experimental Medicine

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKaterina Bittenglova
Katerina Bittenglova
KZKlara Zacharovova
Klara Zacharovova
FTFilip Tichanek
Filip Tichanek
ILIvan Leontovyc
Ivan Leontovyc
PGPeter Girman
Peter Girman
TKTomas Koblas
Tomas Koblas
Adult pancreatic β-cells are mostly locked in quiescence, limiting large-scale analysis of their cell cycle. To overcome this limitation, we used synthetic in vitro transcribed mRNAs encoding Cyclin D1 and CDK4 to induce proliferation in up to 70% of primary rat β-cells. Flow cytometry-based analysis of cell-cycle markers revealed substantial heterogeneity in β-cell cell-cycle progression, identifying five distinct groups of proliferating β-cells based on G1 entry timing. Total cell-cycle length ranged from approximately 26 to 34 hours and was primarily determined by variability in G1 duration (13-19 hours). In the fastest-dividing β-cells, G1, S, and G2M lasted approximately 13, 6, and 7 hours, respectively, whereas later-entering β-cells exhibited progressively longer G1 phase. Additionally, we identified a small β-cell subpopulation that failed to complete division and may have exited the cell cycle. These findings reveal cell-cycle entry and G1 progression as a major source of heterogeneity in β-cell proliferation and provide quantitative benchmark for developing strategies to enhance controlled β-cell regeneration in diabetes.